SOPH SOPHiA GENETICS SA: institutional ownership and insider trading
73 funds reported holding $228M of SOPHiA GENETICS SA in their latest 13F filings; in Q2 2026 funds net bought $75.7M, with 25 new positions and 3 funds selling out; over the last 12 months insiders bought $99.0K and sold $5.18M on the open market.
Famous investors holding SOPH
- Chuck Akre (Akre Capital Management): $21.5M, 0.4% of the portfolio
- Ken Griffin (Citadel Advisors): $1.08M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $799K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $654K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $337K, 0.0% of the portfolio
Largest institutional holders of SOPH
- GENERATION INVESTMENT MANAGEMENT LLP — $39.2M
- AIGH Capital Management LLC — $22.8M
- AKRE CAPITAL MANAGEMENT LLC — $21.5M
- ROYCE & ASSOCIATES LP — $19.5M
- BANQUE PICTET & CIE SA — $18.5M
- PRINCIPAL FINANCIAL GROUP INC (PFG) — $13.6M
- AMERIPRISE FINANCIAL INC (AMP) — $12.8M
- AWM Investment Company, Inc. — $9.81M
- Soleus Capital Management, L.P. — $9.03M
- SILVERCREST ASSET MANAGEMENT GROUP LLC — $8.24M
Recent SOPH insider trades
- Oct 13, 2026: Xu Zhenyu sold 4,000 shares ($28.7K)
- Oct 12, 2026: Camblong Jurgi sold 8,500 shares ($61.7K)
- Oct 12, 2026: Menu Philippe sold 5,000 shares ($36.3K)
- Oct 5, 2026: Muken Ross sold 9,838 shares ($80.0K)
5%+ owners
- AKRE CAPITAL MANAGEMENT, LLC: 5.6% (Schedule 13G, filed Jun 27, 2025)